# FDA UNTITLED_LETTER - Pavilion Compounding Pharmacy - November 06, 2020

Source: https://www.keypedia.com/records/untitled_letter/pavilion-compounding-pharmacy/092f11a3-fd9c-4e11-a299-b66a20a7130f

> FDA UNTITLED_LETTER for Pavilion Compounding Pharmacy on November 06, 2020. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: UNTITLED_LETTER
- Company Name: Pavilion Compounding Pharmacy
- Inspection Date: 2020-11-06
- Product Type: Drugs

## Related Documents

- [OTHER_CORRESPONDENCE - 2019-02-08](https://www.keypedia.com/records/other_correspondence/pavilion-compounding-pharmacy/851232bf-4369-4edb-99d3-1838f318f5d9)
- [483 - 2019-02-08](https://www.keypedia.com/records/483/pavilion-compounding-pharmacy/488bb8d0-d9cc-4ee2-bfbf-cf0011b3f421)
- [UNTITLED_LETTER - 2020-12-09](https://www.keypedia.com/records/untitled_letter/pavilion-compounding-pharmacy/1c3ef15f-b01f-4a58-aab1-49c4978ba55e)

## Related Officers

- [Program Division Director](https://www.keypedia.com/people/monica-r-maxwell/e1b3373a-80b0-4023-9aea-b4ac7170c964)

Company: https://www.keypedia.com/companies/pavilion-compounding-pharmacy/3ad06513-e2ae-469c-a980-4cae2c1567ff